MATA NATHAN L. (Chief Scientific Officer) sold 15.0% of their position (1K shares) of BELITE BIO, INC on the open market
Open‑market sale worth $155.8K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 5 sales
Filed: 4/30/2026ACC: 0001193125-26-197320
Officer· Chief Scientific Officer
Since Mar 2026
-1K
Net shares
Net seller
$155.8K
Total sold
5
Open market trades
0B · 5S
5
Total transactions
1K disposed
Non-Derivative Transactions5
American depositary share
Direct
Shares
−278.00
Price / share
$154.58
Trade value
$42.97K
% of position
4.2%
4/29/2026
6.67K→6.39K
American depositary share
Direct
Shares
−259.00
Price / share
$155.52
Trade value
$40.28K
% of position
4.1%
4/29/2026
6.39K→6.13K
American depositary share
Direct
Shares
−339.00
Price / share
$156.43
Trade value
$53.03K
% of position
5.5%
4/29/2026
6.13K→5.79K
American depositary share
Direct
Shares
−102.00
Price / share
$157.39
Trade value
$16.05K
% of position
1.8%
4/29/2026
5.79K→5.69K
American depositary share
Direct
Shares
−22.00
Price / share
$158.19
Trade value
$3.48K
% of position
0.4%
4/29/2026
5.69K→5.67K
Total
Net shares
−1K
Net value
-$155.82K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| American depositary share Direct | 4/29/2026 | S · Sale | −278.00 | $154.58 | $42.97K | 4.2% | 6.67K | 6.39K |
| American depositary share Direct | 4/29/2026 | S · Sale | −259.00 | $155.52 | $40.28K | 4.1% | 6.39K | 6.13K |
| American depositary share Direct | 4/29/2026 | S · Sale | −339.00 | $156.43 | $53.03K | 5.5% | 6.13K | 5.79K |
| American depositary share Direct | 4/29/2026 | S · Sale | −102.00 | $157.39 | $16.05K | 1.8% | 5.79K | 5.69K |
| American depositary share Direct | 4/29/2026 | S · Sale | −22.00 | $158.19 | $3.48K | 0.4% | 5.69K | 5.67K |
| Total | −1K | -$155.82K | ||||||
Derivative Transactions0
No derivative transactions reported